|

Vasopressor Agents in Pulmonary Hypertension Crisis

RECRUITINGN/ASponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
PhaseN/A
SponsorChina National Center for Cardiovascular Diseases
Started2026-08-19
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age \> 18 years old;
2. Signed informed consent form;
3. Confirmed diagnosis of arterial pulmonary hypertension (PAH) and/or chronic thromboembolic pulmonary hypertension (CTEPH);
4. Presenting with manifestations of pulmonary hypertensive crisis;
5. Receiving both diagnosis and treatment in-hospital;
6. No intravenous administration of the vasopressor drugs (including dopamine, norepinephrine, and epinephrine) under study at enrollment.

Exclusion Criteria:

1. At SCAI stage D or stage E ;
2. Patients who only receive a diagnosis but no treatment in the hospital;
3. Uncontrolled hyperthyroidism;
4. Complicated with angle-closure glaucoma;
5. Hypersensitivity to the study drug;
6. Ongoing use of halogenated hydrocarbon general anesthetics such as cyclopropane and halothane;
7. Ongoing use of monoamine oxidase inhibitor (MAOI) antidepressants or anti-Parkinson drugs (phenelzine, tranylcypromine, isocarboxazid, moclobemide);
8. Pregnancy;
9. Already receiving the vasopressor drugs (dopamine, norepinephrine, epinephrine) under study at enrollment.

Conditions4

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Heart DiseaseHypertension, PulmonaryPulmonary Arterial Hypertension (PAH)

Interventions3

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.